Pub Date : 2022-04-22DOI: 10.21926/obm.icm.2203026
J. Bagot
The application of targeted therapies (TT) in oncology has prolonged survivals and even enabled complete remission of cancers previously considered incurable. With small therapeutic indices, the reduction in dosage or spacing out of the doses of TT due to side effects, represents a significant loss of treatment opportunity for the patients. In the absence of drug interaction and significant side effects, homeopathy used in supportive care improves the quality of life of patients, compliance with oncological treatments and consequently their survival. Based on the author’s clinical experience and published studies, a therapeutic regimen for systematic supportive care of TT is proposed in this study. The originality of the treatment lies in combining a symptomatic diluted and dynamised homeopathic medicine with the patient’s constitutional homeopathic medicine as well as the isotherapeutic agent used for targeted therapy in 7c (10-14). If needs be, the eponymous organotherapy of the organ most affected by the side effects can be added in 4c (10-8). This therapeutic regimen is well accepted and well tolerated. It has been prescribed to approximately 5,000 patients over 25 years including those patients who were given hormone therapy. Facilitating tolerance and acceptance of targeted therapies is very important in oncology in order to fully benefit from the TT efficacy. Homeopathy, organotherapy and isotherapy, by supporting the whole body and treating the major side effects, might improve observance and consequently therapeutic results. Clinical trials could be carried out following the designs and protocols presented in this article.
{"title":"Improving Tolerance and Compliance of New Targeted Therapies with Homeopathy: A Major Challenge in Oncology","authors":"J. Bagot","doi":"10.21926/obm.icm.2203026","DOIUrl":"https://doi.org/10.21926/obm.icm.2203026","url":null,"abstract":"The application of targeted therapies (TT) in oncology has prolonged survivals and even enabled complete remission of cancers previously considered incurable. With small therapeutic indices, the reduction in dosage or spacing out of the doses of TT due to side effects, represents a significant loss of treatment opportunity for the patients. In the absence of drug interaction and significant side effects, homeopathy used in supportive care improves the quality of life of patients, compliance with oncological treatments and consequently their survival. Based on the author’s clinical experience and published studies, a therapeutic regimen for systematic supportive care of TT is proposed in this study. The originality of the treatment lies in combining a symptomatic diluted and dynamised homeopathic medicine with the patient’s constitutional homeopathic medicine as well as the isotherapeutic agent used for targeted therapy in 7c (10-14). If needs be, the eponymous organotherapy of the organ most affected by the side effects can be added in 4c (10-8). This therapeutic regimen is well accepted and well tolerated. It has been prescribed to approximately 5,000 patients over 25 years including those patients who were given hormone therapy. Facilitating tolerance and acceptance of targeted therapies is very important in oncology in order to fully benefit from the TT efficacy. Homeopathy, organotherapy and isotherapy, by supporting the whole body and treating the major side effects, might improve observance and consequently therapeutic results. Clinical trials could be carried out following the designs and protocols presented in this article.","PeriodicalId":74333,"journal":{"name":"OBM integrative and complimentary medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48566972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-12DOI: 10.21926/obm.icm.2202022
H. Hazlett-Stevens
Mindfulness-based stress reduction (MBSR) teaches mindfulness meditation to reduce stress, anxiety, depression, and related forms of distress among a variety of patients. Much research has documented statistically significant reductions across a variety of self-report measures following MBSR, but researchers rarely assessed and reported the clinical significance of MBSR symptom reduction in accordance with specific criteria famously established by Jacobson and Truax [1]. Patients reporting symptoms of anxiety, depression, and/or other stress-related concerns received MBSR in an outpatient mental health clinic. In order to assess the clinical significance of reported symptom reduction, specific criteria to determine reliable clinical improvement and recovery were applied to the data from each patient across the main symptom outcome measures. This secondary clinical significance analysis was conducted with all 23 patients who completed MBSR and completed assessment measures both before and after the intervention in the original open trial. A reliable change index and a cutoff point for outcome measures of worry, depression, anxiety, and stress were obtained so that reliable clinical improvement and recovery on each measure could be assessed for each patient. The proportion of patients who were elevated in the clinical range above the cutoff before the intervention was determined, as well as the proportion of those reporting symptom reduction, the proportion showing reliable improvement, and the proportion recovered at the final MBSR session. Clinical significance analyses revealed that over half of the patient sample scored in the clinical range on each measure before MBSR. At the end of the intervention, the vast majority of these patients reported symptom reduction, and depending on the measure, 45-69% of patients who were clinically elevated initially and reported symptom reduction following MBSR exhibited reliable clinical improvement. Furthermore, 29-50% of those patients showing reliable clinical improvement also met criteria as recovered at the conclusion of the MBSR program. These results suggest that the symptom reduction observed following MBSR is substantial and clinically meaningful for many patients – an outcome that cannot be determined with statistical tests of significance alone. Clinical significance criteria, such as those applied in this study, could be implemented in randomized controlled trial protocols to supplement conventional tests of statistical significance and shed light on how clinically meaningful obtained changes on outcome measures are for patients.
{"title":"Clinical Significance of Stress, Depression, Anxiety, and Worry Symptom Improvement Following Mindfulness-based Stress Reduction","authors":"H. Hazlett-Stevens","doi":"10.21926/obm.icm.2202022","DOIUrl":"https://doi.org/10.21926/obm.icm.2202022","url":null,"abstract":"Mindfulness-based stress reduction (MBSR) teaches mindfulness meditation to reduce stress, anxiety, depression, and related forms of distress among a variety of patients. Much research has documented statistically significant reductions across a variety of self-report measures following MBSR, but researchers rarely assessed and reported the clinical significance of MBSR symptom reduction in accordance with specific criteria famously established by Jacobson and Truax [1]. Patients reporting symptoms of anxiety, depression, and/or other stress-related concerns received MBSR in an outpatient mental health clinic. In order to assess the clinical significance of reported symptom reduction, specific criteria to determine reliable clinical improvement and recovery were applied to the data from each patient across the main symptom outcome measures. This secondary clinical significance analysis was conducted with all 23 patients who completed MBSR and completed assessment measures both before and after the intervention in the original open trial. A reliable change index and a cutoff point for outcome measures of worry, depression, anxiety, and stress were obtained so that reliable clinical improvement and recovery on each measure could be assessed for each patient. The proportion of patients who were elevated in the clinical range above the cutoff before the intervention was determined, as well as the proportion of those reporting symptom reduction, the proportion showing reliable improvement, and the proportion recovered at the final MBSR session. Clinical significance analyses revealed that over half of the patient sample scored in the clinical range on each measure before MBSR. At the end of the intervention, the vast majority of these patients reported symptom reduction, and depending on the measure, 45-69% of patients who were clinically elevated initially and reported symptom reduction following MBSR exhibited reliable clinical improvement. Furthermore, 29-50% of those patients showing reliable clinical improvement also met criteria as recovered at the conclusion of the MBSR program. These results suggest that the symptom reduction observed following MBSR is substantial and clinically meaningful for many patients – an outcome that cannot be determined with statistical tests of significance alone. Clinical significance criteria, such as those applied in this study, could be implemented in randomized controlled trial protocols to supplement conventional tests of statistical significance and shed light on how clinically meaningful obtained changes on outcome measures are for patients.","PeriodicalId":74333,"journal":{"name":"OBM integrative and complimentary medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46361836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-11DOI: 10.21926/obm.icm.2203029
Rachel Hull, S. Browning, Melanie Puzio
The authors attempted to operationalize the clinical work of strategic theorist and expert family therapist, Scott Browning. Strategic therapy takes the position that a client is stuck, not necessarily sick. This focus encourages the clinician to create alternative perspectives such that a client learns to consider a problem from a new lens. Milton Erickson, a progenitor of strategic thinking, used hypnosis and paradox to nudge clients toward a useful alternative perspective [1]. The present article examined three interventions that have strategic roots. The specific application of these three interventions, demonstrated through the work of Browning’s therapy, provide unique application of strategic ideas. First, the authors compare and contrast Browning and Erickson’s [1] application of directional and non-directional paradox. Second, the well-established technique of systemic reframe is explored, along with application of acceptance. Next, empathy is discussed in the context of the common factor of therapeutic alliance [2] and Browning’s understanding of empathy. Finally, the importance of language in psychotherapy is particularly powerful in the context of hypnosis [1]. Browning’s semantic thoroughness and the concept of non-blaming precision in clinical work was discussed.
{"title":"Induction into Browning’s Strategy: Suggestions for Family Therapy","authors":"Rachel Hull, S. Browning, Melanie Puzio","doi":"10.21926/obm.icm.2203029","DOIUrl":"https://doi.org/10.21926/obm.icm.2203029","url":null,"abstract":"The authors attempted to operationalize the clinical work of strategic theorist and expert family therapist, Scott Browning. Strategic therapy takes the position that a client is stuck, not necessarily sick. This focus encourages the clinician to create alternative perspectives such that a client learns to consider a problem from a new lens. Milton Erickson, a progenitor of strategic thinking, used hypnosis and paradox to nudge clients toward a useful alternative perspective [1]. The present article examined three interventions that have strategic roots. The specific application of these three interventions, demonstrated through the work of Browning’s therapy, provide unique application of strategic ideas. First, the authors compare and contrast Browning and Erickson’s [1] application of directional and non-directional paradox. Second, the well-established technique of systemic reframe is explored, along with application of acceptance. Next, empathy is discussed in the context of the common factor of therapeutic alliance [2] and Browning’s understanding of empathy. Finally, the importance of language in psychotherapy is particularly powerful in the context of hypnosis [1]. Browning’s semantic thoroughness and the concept of non-blaming precision in clinical work was discussed.","PeriodicalId":74333,"journal":{"name":"OBM integrative and complimentary medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41374913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-04-02DOI: 10.21926/obm.icm.2202018
Interview with Dr. James David Adams. The skin is where pain is sensed and where chronic pain is created. The safest and most effective treatment for pain is topical plant medicines. Chronic pain can be cured with topical plant medicines. Transient receptor potential cation channels in the skin sense pain. Chronic pain involves a pain chemokine cycle. Monoterpenoids and diterpenoids from plants can stop this pain chemokine cycle and cure chronic pain.
{"title":"An Interview with Dr. James David Adams","authors":"","doi":"10.21926/obm.icm.2202018","DOIUrl":"https://doi.org/10.21926/obm.icm.2202018","url":null,"abstract":"Interview with Dr. James David Adams. The skin is where pain is sensed and where chronic pain is created. The safest and most effective treatment for pain is topical plant medicines. Chronic pain can be cured with topical plant medicines. Transient receptor potential cation channels in the skin sense pain. Chronic pain involves a pain chemokine cycle. Monoterpenoids and diterpenoids from plants can stop this pain chemokine cycle and cure chronic pain.","PeriodicalId":74333,"journal":{"name":"OBM integrative and complimentary medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45851871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-08DOI: 10.21926/obm.icm.2203031
R. Baillargeon, M. Charette, François Tessier, K. Brand
The current recommendations of the Canadian Paediatric Society about monitoring children’s disruptive behaviors at well-child visits call for screening if behavioral concerns are being raised by parents. But do parents’ concerns about their child’s behavior constitute a reliable means for primary care providers (PCPs) to decide either in favor or against screening? We conducted a rapid systematic review of the literature by identifying documents that cited the landmark study by Glascoe and her colleagues (1991) on the accuracy of behavioral concerns at identifying children with a disruptive behavior problem. Citation tracking was done using Web of Science (Core Collection; 17 October 2018) and SCOPUS (19 October 2018). Only one recent published study was identified. The calibration of concerns’ specificity (and other indices alike) yielded, at best, a fair value of the weighted kappa coefficient κ(0,0) (i.e., 0.255 and 0.094). Also, the calibration of concerns’ sensitivity (and other indices alike) yielded, at best, a moderate value of the weighted kappa coefficient κ(1,0) (i.e., 0.533 and 0.392). Overall, the results do not support the current recommendations. In fact, behavioral concerns do not provide PCPs with enough information to reach a decision about screening. We discuss different ways of gathering the necessary information.
加拿大儿科学会目前的建议是，在健康儿童访视中监测儿童的破坏性行为，要求对父母是否提出了行为担忧进行筛查。但是，父母对孩子行为的担忧是否构成初级保健提供者(pcp)决定支持或反对筛查的可靠手段?我们对文献进行了快速系统的回顾，找出了引用Glascoe和她的同事(1991)的里程碑式研究的文件，该研究是关于行为关注在识别具有破坏性行为问题的儿童方面的准确性。引文跟踪使用Web of Science (Core Collection;2018年10月17日)和SCOPUS(2018年10月19日)。只有最近发表的一项研究得到了证实。对关注的特异性(以及其他类似的指标)的校准最多产生一个加权kappa系数κ(0,0)的公允值(即0.255和0.094)。此外，对关注点的敏感性(以及其他类似指标)的校准最多产生一个加权kappa系数κ(1,0)的中等值(即0.533和0.392)。总的来说，研究结果并不支持目前的建议。事实上，对行为的关注并不能为pcp提供足够的信息来决定是否进行筛查。我们讨论了收集必要信息的不同方法。
{"title":"Clinical Practice Guidelines About Screening for Disruptive Behavior Problems at Well-Child Visits: A Rapid Review of the Literature on the Accuracy of Parents’ Behavioral Concerns","authors":"R. Baillargeon, M. Charette, François Tessier, K. Brand","doi":"10.21926/obm.icm.2203031","DOIUrl":"https://doi.org/10.21926/obm.icm.2203031","url":null,"abstract":"The current recommendations of the Canadian Paediatric Society about monitoring children’s disruptive behaviors at well-child visits call for screening if behavioral concerns are being raised by parents. But do parents’ concerns about their child’s behavior constitute a reliable means for primary care providers (PCPs) to decide either in favor or against screening? We conducted a rapid systematic review of the literature by identifying documents that cited the landmark study by Glascoe and her colleagues (1991) on the accuracy of behavioral concerns at identifying children with a disruptive behavior problem. Citation tracking was done using Web of Science (Core Collection; 17 October 2018) and SCOPUS (19 October 2018). Only one recent published study was identified. The calibration of concerns’ specificity (and other indices alike) yielded, at best, a fair value of the weighted kappa coefficient κ(0,0) (i.e., 0.255 and 0.094). Also, the calibration of concerns’ sensitivity (and other indices alike) yielded, at best, a moderate value of the weighted kappa coefficient κ(1,0) (i.e., 0.533 and 0.392). Overall, the results do not support the current recommendations. In fact, behavioral concerns do not provide PCPs with enough information to reach a decision about screening. We discuss different ways of gathering the necessary information.","PeriodicalId":74333,"journal":{"name":"OBM integrative and complimentary medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46831447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-03-07DOI: 10.21926/obm.icm.2203028
Julia Caldwell, P. Meredith, K. Whittingham, J. Ziviani
Positive perceptions of pregnancy are associated with better postpartum outcomes, including stronger relationship with baby. Although better self-reported emotional availability (EA-SR) is associated with greater attachment security with infants, research has not yet explored the relationship between prenatal maternal factors and EA-SR. The aim of the study was to explore the associations between prenatal variables (adult attachment, shame, compassion) and EA-SR at 3- and 6-months postpartum. A cross-sectional survey design based on a convenience sample of pregnant Australian women completed the survey at three time points: pregnancy (3rd trimester, n = 133), and again at 3- (n = 65) and 6-months (n = 40) postpartum. Five, 5-step, hierarchical multiple regressions revealed the model (mean maternal age/prenatal attachment/shame/compassion/psychological adjustment) significantly explained 62% in self-reported maternal hostility, 53% in self-reported child involvement, and 52% in self-reported mutual attunement, at 6-months postpartum. Higher levels of prenatal internal shame were related to less self-reported child involvement (p = 0.04), and more self-reported maternal hostility (p = 0.03), at 3-months postpartum. More prenatal giving compassion was associated with better self-reported affect quality at 3- (p = 0.01) and 6-months postpartum (p = 0.01), and less self-reported hostility (p = 0.02) at 6-months postpartum. Greater understanding of the relationship between prenatal factors and EA-SR may help enhance prenatal care pathways to support women and families at risk of adverse postpartum outcomes.
{"title":"Associations between Prenatal Factors and Self-Reported Emotional Availability at 3- and 6-Months Postpartum","authors":"Julia Caldwell, P. Meredith, K. Whittingham, J. Ziviani","doi":"10.21926/obm.icm.2203028","DOIUrl":"https://doi.org/10.21926/obm.icm.2203028","url":null,"abstract":"Positive perceptions of pregnancy are associated with better postpartum outcomes, including stronger relationship with baby. Although better self-reported emotional availability (EA-SR) is associated with greater attachment security with infants, research has not yet explored the relationship between prenatal maternal factors and EA-SR. The aim of the study was to explore the associations between prenatal variables (adult attachment, shame, compassion) and EA-SR at 3- and 6-months postpartum. A cross-sectional survey design based on a convenience sample of pregnant Australian women completed the survey at three time points: pregnancy (3rd trimester, n = 133), and again at 3- (n = 65) and 6-months (n = 40) postpartum. Five, 5-step, hierarchical multiple regressions revealed the model (mean maternal age/prenatal attachment/shame/compassion/psychological adjustment) significantly explained 62% in self-reported maternal hostility, 53% in self-reported child involvement, and 52% in self-reported mutual attunement, at 6-months postpartum. Higher levels of prenatal internal shame were related to less self-reported child involvement (p = 0.04), and more self-reported maternal hostility (p = 0.03), at 3-months postpartum. More prenatal giving compassion was associated with better self-reported affect quality at 3- (p = 0.01) and 6-months postpartum (p = 0.01), and less self-reported hostility (p = 0.02) at 6-months postpartum. Greater understanding of the relationship between prenatal factors and EA-SR may help enhance prenatal care pathways to support women and families at risk of adverse postpartum outcomes.","PeriodicalId":74333,"journal":{"name":"OBM integrative and complimentary medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42926209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-02-25DOI: 10.21926/obm.icm.2201013
M. I. Yakubu, Nahu Mohammed Danjamu, M. Magaji, S. Malami, A. Becker, M. Abbas, B. Chindo
Preparations of Zingiber officinale are used in Nigerian folk medicine to manage colds, pain, arthritis, nausea, and epilepsy. The ameliorative effects of co-administering aqueous Zingiber officinale extract (GE) and sodium valproate (SDV) on pentylenetetrazole-kindled mice were evaluated regarding cognitive deficits, neuronal cell loss, and seizure severity. GFAP was also quantified. Male mice were pretreated with GE (50 mg/kg), SDV (100 and 200 mg/kg), and GE + SDV before kindling. After kindling, the mice underwent a learning performance test. The animals received a challenge dose of pentylenetetrazole one week after kindling. The brains were excised one day after the challenge test and were processed for GFAP immunohistochemistry and histopathology. GE alone did not affect PTZ-kindled seizures. However, treatment with GE and SDV significantly improved learning performance and protected against neuronal cell loss in pentylenetetrazole-kindled mice. The level of astrocyte activation was reduced in the kindled group pretreated with the extract. The results obtained suggested that co-administration of GE and a low dose of SDV significantly ameliorated learning deficits and protected against neuronal cell loss, astrogliosis, and neuroinflammation, suggesting that GE might be a beneficial co-medication in the management of epilepsy.
{"title":"Co-administration of Zingiber officinale Extract and Sodium Valproate Ameliorates Seizure Severity, Cognitive Deficit, and Neuronal Cell Loss in Pentylenetetrazole-kindled Mice","authors":"M. I. Yakubu, Nahu Mohammed Danjamu, M. Magaji, S. Malami, A. Becker, M. Abbas, B. Chindo","doi":"10.21926/obm.icm.2201013","DOIUrl":"https://doi.org/10.21926/obm.icm.2201013","url":null,"abstract":"Preparations of Zingiber officinale are used in Nigerian folk medicine to manage colds, pain, arthritis, nausea, and epilepsy. The ameliorative effects of co-administering aqueous Zingiber officinale extract (GE) and sodium valproate (SDV) on pentylenetetrazole-kindled mice were evaluated regarding cognitive deficits, neuronal cell loss, and seizure severity. GFAP was also quantified. Male mice were pretreated with GE (50 mg/kg), SDV (100 and 200 mg/kg), and GE + SDV before kindling. After kindling, the mice underwent a learning performance test. The animals received a challenge dose of pentylenetetrazole one week after kindling. The brains were excised one day after the challenge test and were processed for GFAP immunohistochemistry and histopathology. GE alone did not affect PTZ-kindled seizures. However, treatment with GE and SDV significantly improved learning performance and protected against neuronal cell loss in pentylenetetrazole-kindled mice. The level of astrocyte activation was reduced in the kindled group pretreated with the extract. The results obtained suggested that co-administration of GE and a low dose of SDV significantly ameliorated learning deficits and protected against neuronal cell loss, astrogliosis, and neuroinflammation, suggesting that GE might be a beneficial co-medication in the management of epilepsy.","PeriodicalId":74333,"journal":{"name":"OBM integrative and complimentary medicine","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68396556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-02-06DOI: 10.21926/obm.icm.2202020
Em V. Adams, B. Crowe, Jasmine Vanadore, M. V. Puymbroeck, A. Schmid
The purpose of this descriptive survey was to explore how, and for what purpose, health care practitioners use yoga in clinical practice. A survey was administered to professionals who identified as healthcare practitioners who used yoga in their practice. There were 205 completed responses from a combination of healthcare practitioners including occupational therapists, physical therapists, yoga therapists, recreational therapists, speech-language pathologists, and mental health counselors. Practitioners worked in outpatient, community, and acute rehab settings. Open-ended survey questions were analyzed using directed content analysis. Themes included how to discuss and document yoga, selecting yoga based on patient preference and clinical judgment, and finally, practitioners’ recommendations for implementing yoga into practice. Implications of the study are further discussed.
{"title":"The Use of Yoga in Clinical Practice: A Descriptive Study","authors":"Em V. Adams, B. Crowe, Jasmine Vanadore, M. V. Puymbroeck, A. Schmid","doi":"10.21926/obm.icm.2202020","DOIUrl":"https://doi.org/10.21926/obm.icm.2202020","url":null,"abstract":"The purpose of this descriptive survey was to explore how, and for what purpose, health care practitioners use yoga in clinical practice. A survey was administered to professionals who identified as healthcare practitioners who used yoga in their practice. There were 205 completed responses from a combination of healthcare practitioners including occupational therapists, physical therapists, yoga therapists, recreational therapists, speech-language pathologists, and mental health counselors. Practitioners worked in outpatient, community, and acute rehab settings. Open-ended survey questions were analyzed using directed content analysis. Themes included how to discuss and document yoga, selecting yoga based on patient preference and clinical judgment, and finally, practitioners’ recommendations for implementing yoga into practice. Implications of the study are further discussed.","PeriodicalId":74333,"journal":{"name":"OBM integrative and complimentary medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42728422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-02-03DOI: 10.21926/obm.icm.2201012
P. G. Vassão, E. Laakso
Photobiomodulation therapy (PBMT) for minimal to moderate Kellgren and Lawrence grade knee osteoarthritis has significant evidence for effectiveness. The effect of PBMT in severe grades of osteoarthritis is less clear; and no studies have investigated the effect of PBMT before and after knee replacement surgery. This small study (n=4) aimed to understand the potential feasibility of undertaking a future randomised controlled clinical trial of a self-administered, home-based light patch system before and after total knee arthroplasty (TKA) The PBM device (450nm (6.75 mW/cm2) and 640nm (2.25 mW/cm2); 33kHz frequency, 4.5 J/cm2 radiant exposure) was self-applied by patients daily for 30 minutes for one week before, and 3 times in the week following hospital discharge after TKA. We measured numeric pain ratings, physical function and patient-reported outcomes at baseline one week prior to surgery, the day prior to surgery, at Day 4 after surgery, and at 1, 2, 4 and 6 weeks after hospital discharge. The study protocol and methods were found to be feasible and acceptable to participants. No pain was reported by any participants at 6-week follow-up. Functional measures of timed-up-and-go and 30 second chair stands test demonstrated marked improvement over the study period. No patients were requiring opioid analgesia at 6-week follow-up. Limitations included lack of gender diversity, the small number of participants and absence of information about post-hospital discharge opioid analgesic requirements from control group. The results provide confidence in progressing this research in an adequately powered, placebo-controlled, randomised clinical trial.
{"title":"Photobiomodulation Therapy (PBMT) is Feasible and Acceptable in Pre-conditioning and Post-operative Recovery of Patients after Total Knee arthroplasty (TKA): A Clinical Case Series","authors":"P. G. Vassão, E. Laakso","doi":"10.21926/obm.icm.2201012","DOIUrl":"https://doi.org/10.21926/obm.icm.2201012","url":null,"abstract":"Photobiomodulation therapy (PBMT) for minimal to moderate Kellgren and Lawrence grade knee osteoarthritis has significant evidence for effectiveness. The effect of PBMT in severe grades of osteoarthritis is less clear; and no studies have investigated the effect of PBMT before and after knee replacement surgery. This small study (n=4) aimed to understand the potential feasibility of undertaking a future randomised controlled clinical trial of a self-administered, home-based light patch system before and after total knee arthroplasty (TKA) The PBM device (450nm (6.75 mW/cm2) and 640nm (2.25 mW/cm2); 33kHz frequency, 4.5 J/cm2 radiant exposure) was self-applied by patients daily for 30 minutes for one week before, and 3 times in the week following hospital discharge after TKA. We measured numeric pain ratings, physical function and patient-reported outcomes at baseline one week prior to surgery, the day prior to surgery, at Day 4 after surgery, and at 1, 2, 4 and 6 weeks after hospital discharge. The study protocol and methods were found to be feasible and acceptable to participants. No pain was reported by any participants at 6-week follow-up. Functional measures of timed-up-and-go and 30 second chair stands test demonstrated marked improvement over the study period. No patients were requiring opioid analgesia at 6-week follow-up. Limitations included lack of gender diversity, the small number of participants and absence of information about post-hospital discharge opioid analgesic requirements from control group. The results provide confidence in progressing this research in an adequately powered, placebo-controlled, randomised clinical trial.","PeriodicalId":74333,"journal":{"name":"OBM integrative and complimentary medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41614420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-01-28DOI: 10.21926/obm.icm.2202021
Z. Arnon
After the emergence of Mindfulness in the Western world, many studies proved its mental and physical benefits. However, implementing Mindfulness in psychotherapy has several challenges: therapists are not formal Mindfulness instructors; the Mindfulness course is a continuous eight-week course, which many patients do not attend during therapy, while others attend and drop out. Thus, Hypnosis was applied to shorten and strengthen the desired changes. The article describes the logic behind this integration, demonstrates it using a case study, and details the ideas, philosophy, and hypnotic scripts in the appendix.
{"title":"Integrating Mindfulness Practice in Cognitive Behavioral Hypnotic Psychotherapy","authors":"Z. Arnon","doi":"10.21926/obm.icm.2202021","DOIUrl":"https://doi.org/10.21926/obm.icm.2202021","url":null,"abstract":"After the emergence of Mindfulness in the Western world, many studies proved its mental and physical benefits. However, implementing Mindfulness in psychotherapy has several challenges: therapists are not formal Mindfulness instructors; the Mindfulness course is a continuous eight-week course, which many patients do not attend during therapy, while others attend and drop out. Thus, Hypnosis was applied to shorten and strengthen the desired changes. The article describes the logic behind this integration, demonstrates it using a case study, and details the ideas, philosophy, and hypnotic scripts in the appendix.","PeriodicalId":74333,"journal":{"name":"OBM integrative and complimentary medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42922131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：